SCHEMBL5204094

SCHEMBL5204094

CCCCOC(=O)C(N)(CN)C(=O)O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.44
ATM Q13315 1/20 0.41
HCAR2 Q8TDS4 3/20 0.41
TSHR P16473 5/20 0.39
HPGD P15428 1/20 0.39
HSD17B10 Q99714 1/20 0.38
LMNA P02545 2/20 0.37
CYP1A2 P05177 2/20 0.37
CYP2C19 P33261 2/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2C9 P11712 1/20 0.37
PDE4D Q08499 1/20 0.37
HTR2C P28335 1/20 0.37
NAAA Q02083 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
MAPT P10636 1/20 0.36
RAB9A P51151 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
EPHX1 P07099 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL7377198 0.98 ALDH1A1 (0.42) ALDH1A1ATMHCAR2TSHRHPGD
SCHEMBL5852966 0.95 NAAA (0.43) ALDH1A1ATMHCAR2TSHRHSD17B10
SCHEMBL7371516 0.89 HCAR2 (0.37) ALDH1A1HCAR2TSHRLMNATDP1
SCHEMBL3981178 0.87 ALDH1A1 (0.45) ALDH1A1ATMHCAR2TSHRHPGD
SCHEMBL28249791 0.86 ALDH1A1 (0.44) ALDH1A1ATMHCAR2TSHRHPGD
SCHEMBL27795945 0.84 ALDH1A1 (0.42) ALDH1A1ATMHCAR2TSHRHPGD
SCHEMBL27596964 0.84 ALDH1A1 (0.42) ALDH1A1ATMHCAR2TSHRHPGD
SCHEMBL28914773 0.83 ALDH1A1 (0.39) ALDH1A1ATMHCAR2TSHRHPGD
SCHEMBL28914772 0.83 ALDH1A1 (0.39) ALDH1A1ATMHCAR2TSHRHPGD
SCHEMBL8591685 0.83 ALDH1A1 (0.41) ALDH1A1ATMHCAR2TSHRHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-10215890-A None JP disclosed
CN-114652816-B Compositions containing HC-HA/PTX3 complexes and methods of use thereof 生物组织控股公司 2025-03-14 CN disclosed
EP-4319556-A1 USE OF ANTI-CLOTTING COMPOUNDS AS RODENTICIDES Gulba, Dietrich (DE) 2024-02-14 EP disclosed
WO-2022214485-A1 USE OF ANTI-CLOTTING COMPOUNDS AS RODENTICIDES BIOROXX GMBH (DE) 2022-10-13 WO disclosed
EP-4070658-A1 USE OF ANTICOAGULANT ACTIVE COMPOUNDS AS RODENTICIDE BIORoxx GmbH (DE) 2022-10-12 EP disclosed
CN-114652816-A Compositions containing HC-HA/PTX3 complexes and methods of use thereof 组织技术公司 2022-06-24 CN disclosed
CN-104619352-B Compositions containing HC-HA/PTX3 complexes and methods of use thereof 组织技术公司 2022-02-18 CN disclosed
WO-2017092759-A1 GEPHYRIN BINDING PEPTIDES AND USES THEREOF UNIVERSITY OF COPENHAGEN (DK) 2017-06-08 WO disclosed
EP-1135374-B9 BENZIMIDAZOLE COMPOUNDS THAT ARE VITRONECTIN RECEPTOR ANTAGONISTS SCHERING CORP (US) 2007-02-21 EP disclosed
EP-1135374-B1 BENZIMIDAZOLE COMPOUNDS THAT ARE VITRONECTIN RECEPTOR ANTAGONISTS SCHERING CORP (US) 2006-09-06 EP disclosed
EP-1135374-A1 BENZIMIDAZOLE COMPOUNDS THAT ARE VITRONECTIN RECEPTOR ANTAGONISTS SCHERING CORPORATION (US) 2001-09-26 EP disclosed
US-6204282-B1 TREATING CANCER, RETINOPATHY, ATHEROSCLEROSIS, VASCULAR RESTENOSIS, OR OSTEOPOROSIS. SCHERING CORPORATION 2001-03-20 US disclosed
EP-0730590-B1 ISOXAZOLINE AND ISOXAZOLE FIBRINOGEN RECEPTOR ANTAGONISTS DU PONT PHARM CO (US) 2001-01-17 EP disclosed
WO-2000032578-A1 BENZIMIDAZOLE COMPOUNDS THAT ARE VITRONECTIN RECEPTOR ANTAGONISTS SCHERING CORPORATION (US) 2000-06-08 WO disclosed
EP-0970950-A2 Novel isoxazoline and isoxazole fibrinogen receptor antagonists DuPont Pharmaceuticals Company (US) 2000-01-12 EP disclosed
JP-H10215890-A PRODUCTION OF OPTICALLY ACTIVE ALPHA-(N-BUTOXYCARBONYL)-DIAMINOPROPIONIC ACID MITSUBISHI CHEM CORP 1998-08-18 JP disclosed
EP-0730590-A1 NOVEL ISOXAZOLINE AND ISOXAZOLE FIBRINOGEN RECEPTOR ANTAGONISTS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1996-09-11 EP disclosed
WO-1995018111-A1 COMPOUNDS CONTAINING BASIC AND ACIDIC TERMINI USEFUL AS FIBRINOGEN RECEPTOR ANTAGONISTS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1995-07-06 WO disclosed
WO-1995014683-A1 NOVEL ISOXAZOLINE AND ISOXAZOLE FIBRINOGEN RECEPTOR ANTAGONISTS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1995-06-01 WO disclosed